Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer

Molecular Biology Reports

Volumn 41, Issue 5, 2014, Pages 3091-3097

  Çil, Esra ^a   Kumral, Alkin ^b   Kanmaz Özer, Müge ^b   Vural, Pervin ^b   Doǧru Abbasoǧlu, Semra ^b   Altuntaş, Yüksel ^a   Uysal, Müjdat ^b  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

IL 10; IL 6; Papilary thyroid cancer; Polymorphism; TNF

Indexed keywords

CYTOKINE; DNA; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENOTYPE; HEREDITY; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CANCER; THYROIDECTOMY; ALLELE; CARCINOMA; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; RISK; RISK FACTOR; THYROID TUMOR;

ADULT; AGED; ALLELES; CARCINOMA; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THYROID NEOPLASMS;

EID: 84905715706     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3169-7     Document Type: Article

References (41)

1. Khanafshar E, Lloyd RV (2011) The Spectrum of papillary thyroid carcinoma variants. Adv Anat Pathol 18:90-97
2. Lumashi F, Basso SMM, Orlando R (2010) Cytokines, thyroid diseases and thyroid cancer. Cytokine 50:229-233
3. Shizuru JA (2001) Autoimmunitiy and endocrine diseases. In: Greenspan FS, Gardner DG (eds) Basic and clinical endocrinology. Lange Medical Books/McGraw-Hill, New York, pp 745-761
4. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867 (Pubitemid 36019639)
5. Ajan RA, Watson PF, Weetman AP (1996) Cytokines and thyroid function. Adv Neuroimmunol 6:359-386 (Pubitemid 27249231)
6. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JF (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigenspecific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924
7. Rousset F, Garcia T, Defrance T, Vezzio N, Peronne C, Hsu DH, Kastellein R, Moore KW, Banchereau J (1991) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890-1893
8. Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1-10
9. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Köppel H, Wascher TC, Paulweber B, Samonigg H (2005) Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 90:113-115 (Pubitemid 40568894)
10. Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M; Finnish Diabetes Prevention Study (2003) Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52:1872-1876 (Pubitemid 36792481)
11. Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Müller B, Vogelmeier C, von Wichert P (2005) TNF-α-, TNF-β-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 65:93-100 (Pubitemid 40179668)
12. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnot PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8 (Pubitemid 27050850)
13. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumor necrosis factor-a promoter polymorphism effects transcription. Mol Immunol 34:391-399 (Pubitemid 27368335)
14. Pereira DS, Garcia DM, Narciso FMS, Santos MLAS, Dias JMD, Queiroz B, Souza ER, Nobrega OT, Pereira LSM (2012) Effects of IL-6 G/C polymorphism in the promoter region of the interleukin-6 gene on plasma levels and muscle strength in elderly women. Braz J Med Biol Res 44:123-129
15. Sen A, Paine SK, Chowdhury IH, Mukherjee A, Choudhuri S, Saha A, Mandal LK, Bhattacharaya B (2011) Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level of acute inflammation and neovascularization stages of patients with Eales' disease. Mol Vision 17:2552-2556
16. Belluco C, Olivieri F, Bonafe M, Giovagnetti S, Mammano E, Scalerta R, Ambrosi A, Franceschi C, Nitti D, Lise M (2003) -174 G > C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res 9:2173-2176 (Pubitemid 36687640)
17. Baki M, Akman FE, Vural P, Doǧru-Abbasoǧlu S, Özderya A, Karadaǧ B, Uysal M (2012) The combination of Interleukin-10-1082 and Tumor Necrosis Factora-308 or Interleukin-6-174 genes polymorphisms suggests an association with susceptibility to Hashimoto's thyroiditis. Int Immunopharmacol 12:543-546
18. Castro-Santos P, Suarez A, Lopez-Rivas L, Mozo L, Gutierrez C (2006) TNFa and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082AAlowproducer IL-10 genotype with steroid dependency. Am J Gastroenterol 101:1039-1047 (Pubitemid 43725318)
19. Stonek F, Bentz EK, Hafner E, Metzenbauer M, Philipp K, Hefler LA, Tempfer CB (2007) A tumor necrosis factor-α promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1652 pregnant women. Reprod Sci 14:425-429 (Pubitemid 351168797)
20. Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Capurso A, Panza F (2004) Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp Gerontol 39:1567-1573 (Pubitemid 39410558)
21. Kissonergihs AM, Grubeck-Loebestein B, Feldmann M, Londei M (1989) Tumour necrosis factor synergises with gamma interferon on the induction of mRNA alpha chain on thyrocytes from Graves' disease and nontoxic goitre. Autoimmunity 44:255-266 (Pubitemid 19261057)
22. Salvi M, Giarasole C, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E (1998) Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol 81:2976-2979
23. Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre S, Di Gesù G, De Maria R, Stassi G (2006) Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth if thyroid cancer cells. Cancer Res 66:1491-1499 (Pubitemid 43259930)
24. Chen RH, Chen WC, Wang TY, Tsai CH (2005) Lack of association between pto-inflammatory cytokine (IL-6, IL-8 and TNFα) gene polymorphisms and Graves' disease. Int J Immunogenet 32:343-347 (Pubitemid 41735571)
25. Li M, You Q, Wang X (2011) Association between polymorphism of the tumor necrosis factor alpha-308 gene promoter and colon cancer in the Chinese population. Genet Test Mol Biomarkers 15:743-747
26. Singh H, Jain M, Sachan R, Mittal B (2009) Association of TNFα (-308G > A) and IL-10 (819C > T) polymorphisms with the risk of cervical cancer. Int J Gynecol Cancer 19:1190-1194
27. Wei Y, Liu F, Li B, Chen X, Ma Y, Yan L, Wen T, Xu M, Wang W, Yang J (2011) Polymorphisms of tumor necrosisfactoralpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis. Dig Dis Sci 56(8):2227-2236
28. Correa GT, Bandeira GA, Calvacanti BG (2011) de Carvallo Fraga CA, dos Santos EP, Silva TF, Gomez RS, Guimaraes AL, De Paula AM. Oral Oncol 47:888-894
29. Sousa H, Breeda E, Santos AM, Catarino R, Pinto D, Medeiros R (2011) Genetic risk factors for nasolaryngeal carcinoma in Portugal: tomor necrosis factor alpha -308G [ A polymorphism. DNA Cell Biol 30:99-103
30. Kesarwani P, Ahirwar DK, Mandhani A, Mittal RD (2008) Association between -174 G/C promoter polymorphism of the interleukin-6 gene and progression of prostate cancer in North Indian population. DNA Cell Biol 27:505-510
31. Ozgen AG, Karadeniz M, Erdogan M, Berdeli A, Saygili F, Yilmaz C (2009) The (-174) G/C polymorphism inthe iterleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish population. J Endocrinol Invest 32:491-494
32. Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao SM (2010) Lack of association between functional polymorphisms in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25703 subjects. Breast Cancer Res Treat 122:483-488
33. Aladzsty I, Kovacs M, Semsei A, Falus A, Szilagyi A, Karadi I, Varga G, Füst G, Varkonyi J (2009) Comparative analysis of IL-6 promoter and receptor polymorphisms im myelodysplasia and multiple myeloma. Leuk Res 33:1570-1573
34. Eskale J, Kube D, Tesch H, Galagner G (1997) Mapping of the human IL-10 gene and further characterisation of the 5′flanking sequence. Immunogenetics 46:120-128 (Pubitemid 27234709)
35. Erdogan M, Karadeniz M, Ozbek M, Ozgen AG, Berdeli A (2008) Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population. J Endocrinol Invest 31:750-754
36. Cunha LL, Tincani AJ, da Assumpçao LVM, Soares FA, Vasallo J, Ward LS (2011) Interleukin-10 but not interleukin-18 may be associated with the immune response against well differentiated thyroid cancer. Clinics 66:1203-1208
37. Peng WJ, He Q, Yang JX, Wang BX, Lu MM, Wang S, Wang J (2012) Meta-analysis of association between cytokine gene polymorphisms an lung cancer risk. Mol Biol Rep 39:5187-5194
38. Wang J, Ding Q, Shi Y, Cao Q, Qin C, Zhu J, Chen J, Yin C (2012) The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis. Mutagenesis 24:305-312
39. Zhou Y, Hu W, Zhuang W, Wu X (2011) Interleukin-10-1082 promoter polymorphism and gastric cancer risk in Chinese Han population. Mol Cell Biochem 347:89-93
40. Shao N, Zu B, Mi YY, Hua LX (2011) IL-10 polymorphisms and prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis 14:129-135
41. Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB (2006) Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res 66:4525-4530